HES5 silencing is an early and recurrent change in prostate tumourigenesis

Massie, Charlie E., Spiteri, Inmaculada, Ross-Adams, Helen, Luxton, Hayley J., Kay, Jonathan, Whitaker, Hayley C., Dunning, Mark J., Lamb, Alastair D., Ramos-Montoya, Antonio, Brewer, Daniel ORCID: https://orcid.org/0000-0003-4753-9794, Cooper, Colin ORCID: https://orcid.org/0000-0003-2013-8042, Eeles, Rosalind A., Warren, Anne Y., Tavaré, Simon, Neal, David E. and Lynch, Andy G. (2015) HES5 silencing is an early and recurrent change in prostate tumourigenesis. Endocrine-Related Cancer (ERC), 22 (2). pp. 131-144. ISSN 1351-0088

[thumbnail of Massie-et-al-2015-HES5-methylation-in-PrCa-01Jan2015]
PDF (Massie-et-al-2015-HES5-methylation-in-PrCa-01Jan2015) - Accepted Version
Download (808kB) | Preview


Prostate cancer is the most common cancer in men, resulting in over 10,000 deaths per year in the UK. Sequencing and copy number analysis of primary tumours has revealed heterogeneity within tumours and an absence of recurrent founder mutations, consistent with non-genetic disease initiating events. Using methylation profiling in a series of multi-focal prostate tumours we identify promoter methylation of the transcription factor HES5 as an early event in prostate tumourigenesis. We confirm that this epigenetic alteration occurs in 86- 97% of cases in two independent prostate cancer cohorts (n=49 and n=39 tumour-normal pairs). Treatment of prostate cancer cells with the demethylating agent 5-aza-2ʹ′-deoxycytidine increased HES5 expression and down-regulated its transcriptional target HES6, consistent with functional silencing of the HES5 gene in prostate cancer. Finally we identify and test a transcriptional module involving the AR, ERG, HES1 and HES6 and propose a model for the impact of HES5 silencing on tumourigenesis as a starting point for future functional studies.

Item Type: Article
Additional Information: © 2015 The authors This work is licensed under a Creative Commons Attribution 3.0 Unported License
Uncontrolled Keywords: prostate cancer,methylation,hes5,hes6,ar,erg,notch,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies
Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User: Pure Connector
Date Deposited: 09 Mar 2015 07:24
Last Modified: 19 Oct 2023 01:25
URI: https://ueaeprints.uea.ac.uk/id/eprint/52470
DOI: 10.1530/ERC-14-0454


Downloads per month over past year

Actions (login required)

View Item View Item